The Scientist Awaiting CELG Abraxane data on panc CA. SPARC hypothesis controversial. Abrax does not improve OS in breast CA, which is usually SPARC+.
7/31/12
Reply
(2)
•!Report Abuse
View all 2 replies
The Scientist: Perhaps destroying SPARC/stroma promotes metastasis - allows for easier malignant cell escape. Abrax should have worked better in breast CA.
7/31/12
•!Report Abuse
Noreika: Off topic: Did ILNS.PK get halted today? I can't wait to see the Study 301 results!! (the non-carrier one) Or was it the Study 300?
